These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15680729)

  • 1. Fast ventricular tachycardias in patients with implantable cardioverter-defibrillators: efficacy and safety of antitachycardia pacing. A prospective and randomized study.
    Jiménez-Candil J; Arenal A; García-Alberola A; Ortiz M; del Castillo S; Fernández-Portales J; Sánchez-Muñoz J; Martínez-Sánchez J; González-Torrecilla E; Atienza F; Puchol A; Almendral J
    J Am Coll Cardiol; 2005 Feb; 45(3):460-1. PubMed ID: 15680729
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators:
    Sweeney MO
    Pacing Clin Electrophysiol; 2004 Sep; 27(9):1292-305. PubMed ID: 15461721
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of beta-blocker therapy on antitachycardia pacing effectiveness for monomorphic ventricular tachycardias occurring in implantable cardioverter-defibrillator patients: a dose-dependent effect.
    Jiménez-Candil J; Hernández J; Martín A; Ruiz-Olgado M; Herrero J; Ledesma C; Moríñigo J; Martín-Luengo C
    Europace; 2010 Sep; 12(9):1231-8. PubMed ID: 20525727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
    Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
    Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shock Reduction With Antitachycardia Pacing Before and During Charging for Fast Ventricular Tachycardias in Patients With Implantable Defibrillators.
    Dallaglio PD; Anguera I; Martínez Ferrer JB; Pérez L; Viñolas X; Porres JM; Fontenla A; Alzueta J; Martínez JG; Rodríguez A; Basterra N; Sabaté X
    Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):709-717. PubMed ID: 29242102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of different antitachycardia pacing sites in the termination of ventricular tachycardia in patients with biventricular implantable cardioverter-defibrillator.
    Haghjoo M; Hajahmadi M; Fazelifar AF; Sadr-Ameli MA
    Europace; 2011 Apr; 13(4):509-13. PubMed ID: 21296776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study.
    Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E;
    Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
    Sweeney MO; Wathen MS; Volosin K; Abdalla I; DeGroot PJ; Otterness MF; Stark AJ
    Circulation; 2005 Jun; 111(22):2898-905. PubMed ID: 15927965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Sivagangabalan G; Eshoo S; Eipper VE; Thiagalingam A; Kovoor P
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1095-9. PubMed ID: 18834458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study.
    Martins RP; Blangy H; Muresan L; Freysz L; Groben L; Zinzius PY; Schwartz J; Sellal JM; Aliot E; Sadoul N
    Europace; 2012 Oct; 14(10):1457-64. PubMed ID: 22547765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hazards of antitachycardia pacing to treat ventricular tachycardias with implantable cardioverter defibrillators.
    Maass AH; Van Gelder IC
    Europace; 2009 Jun; 11(6):819. PubMed ID: 19357140
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitachycardia pacing: an overview.
    Horwood L; VanRiper S; Davidson T
    Am J Crit Care; 1995 Sep; 4(5):397-404. PubMed ID: 7489045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators.
    Himmrich E; Przibille O; Zellerhoff C; Liebrich A; Rosocha S; Andreas K; Nebeling D; Omogbehin B; Meyer J
    Circulation; 2003 Jul; 108(2):192-7. PubMed ID: 12835212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.
    Grimm W; Plachta E; Maisch B
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of burst pacing, autodecremental (ramp) pacing, and universal pacing for termination of ventricular tachycardia.
    Fisher JD; Zhang Z; Kim SG; Ferrick KJ; Roth JA; Johnston DR
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():135-9. PubMed ID: 8734175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitachycardia pacing: which patients and which methods?
    Rosenqvist M
    Am J Cardiol; 1996 Sep; 78(5A):92-7. PubMed ID: 8820842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the AVID and DAVID trials of implantable defibrillators.
    Sharma A; Epstein AE; Herre JM; Klein RC; Platia EV; Wilkoff B; Ledingham RB; Greene HL; Hallstrom AP;
    Am J Cardiol; 2005 Jun; 95(12):1431-5. PubMed ID: 15950565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single implantable cardioverter-defibrillator shock unmasking an electrical storm of 389 ventricular tachycardia episodes triggering device therapies.
    Arias MA; Valverde I; Puchol A; Castellanos E; Rodríguez-Padial L; Sánchez AM; Alvarez-Temiño M; Palomino M
    Am J Emerg Med; 2008 Nov; 26(9):1066.e1-3. PubMed ID: 19091283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.